Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-18-042890

SVP, General Counsel sold 50,000 shares at $136.46 ($6,823,000)

  • SVP, General Counsel acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Howton David T · SVP, General Counsel

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2018-07-16 Exercise or conversion : show line 1 in the form +3,096 $13.71 $42,446 37,967 D
2018-07-16 Sale : show line 2 in the form −3,096 $136.46 $422,480 34,871 D
2018-07-16 Exercise or conversion : show line 3 in the form +9,056 $13.71 $124,158 43,927 D
2018-07-16 Sale : show line 4 in the form −9,056 $136.46 $1,235,782 34,871 D
2018-07-16 Exercise or conversion : show line 5 in the form +37,848 $13.90 $526,087 72,719 D
2018-07-16 Sale : show line 6 in the form −37,848 $136.46 $5,164,738 34,871 D
Open-market sales · 50,000 sh · avg $136.46 · $6,823,000

Table II: Derivative

3 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2018-07-16 Exercise or conversion : show line 7 in the form Stock option (right to buy) −3,096 $13.71 $42,446 $13.71 2026-02-28 3,096 7,431 D
2018-07-16 Exercise or conversion : show line 8 in the form Stock option (right to buy) −9,056 $13.71 $124,158 $13.71 2026-02-28 9,056 10,090 D
2018-07-16 Exercise or conversion : show line 9 in the form Stock option (right to buy) −37,848 $13.90 $526,087 $13.90 2025-02-27 37,848 27,159 D
Loading xslF345X03/doc4.xml…